Table 5. The relationship between neutrophil platelet score (NPS) and patient demographics in an incidentally sampled cohort of patients with cancer.
| All | NPS = 0 | NPS = 1 | NPS = 2 | p-value | ||
|---|---|---|---|---|---|---|
| n = 9649(%) | n = 5933(%) | n = 2779(%) | n = 937(%) | |||
| Age | <0.001 | |||||
| <65 | 4631 (48) | 3032 (51) | 1170 (42) | 429 (46) | ||
| 65–74 | 2885 (30) | 1696 (29) | 886 (32) | 303 (32) | ||
| >75 | 2133 (22) | 1205 (20) | 723 (26) | 205 (22) | ||
| Sex | <0.001 | |||||
| Female | 4584 (48) | 2646 (45) | 1468 (53) | 470 (50) | ||
| Male | 5065 (52) | 3287 (55) | 1311 (47) | 467 (50) | ||
| Presentation | <0001 | |||||
| Non-Emergency | 6098 (63) | 4236 (71) | 1398 (50) | 464 (50) | ||
| Emergency | 3551 (37) | 1697 (29) | 1381 (50) | 473 (50) | ||
| Tumour Site | <0.001 | |||||
| Breast | 1921 (20) | 1611 (27) | 268 (10) | 42 (5) | ||
| Bladder | 437 (4) | 259 (4) | 128 (5) | 50 (5) | ||
| Gynaecological | 507 (5) | 298 (5) | 142 (5) | 67 (7) | ||
| Prostatic | 509 (5) | 322 (6) | 159 (6) | 28 (3) | ||
| Gastroesophageal | 933 (10) | 548 (9) | 294 (10) | 91 (10) | ||
| Haematological | 914 (9) | 678 (12) | 188 (7) | 48 (5) | ||
| Renal | 459 (5) | 288 (5) | 134 (5) | 37 (4) | ||
| Colorectal | 1086 (11) | 604 (10) | 356 (13) | 126 (13) | ||
| Head And Neck | 633 (7) | 365 (6) | 204 (7) | 64 (7) | ||
| Hepaticopancreaticobiliary | 556 (6) | 309 (5) | 183 (6) | 64 (7) | ||
| Pulmonary | 1694 (18) | 651 (11) | 723 (26) | 320 (34) | ||
| mGPS | <0.001 | |||||
| 0 | 4013 (42) | 3305 (56) | 629 (23) | 79 (9) | ||
| 1 | 2757 (28) | 1504 (25) | 931 (33) | 322 (34) | ||
| 2 | 2879 (30) | 1124 (19) | 1219 (44) | 536 (57) | ||
| Survival Status | <0.001 | |||||
| Alive | 3502 (36) | 2757 (47) | 633 (23) | 112 (12) | ||
| Cancer death | 5218 (54) | 2620 (44) | 1849 (66) | 749 (80) | ||
| Non-cancer death | 929 (10) | 556 (9) | 297 (11) | 76 (8) | ||
| Survival (Months) $ | 21 | 55 | 7 | 3 | <0.001 |
$ median overall survival